Maulana Azad Medical College, Delhi, GB Pant Hospital, Delhi
Holds the highest degrees in Oncology – DrNB, MCh
Having 15+ years of experience in treating
11750+ Patients have been successfully
treated
15+ years of work experience
22+ Awards received by Dr. Shah for his achievements
Benefits of CRS+HIPEC over Traditional Treatments
CRS+HIPEC (Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy) offers significant advantages over traditional treatments:
1. Improved survival rates, especially for peritoneal cavity cancers.
2. Enhanced local control by targeting tumors directly.
3. Reduced systemic toxicity and fewer side effects.
4. Expanded treatment options for previously challenging cancers.
People trust Dr. Harsh Shah with their health when it comes to dealing with HIPEC surgery for cancer – His results speak for themselves!
People trust Dr. Harsh Shah with their health when it comes to dealing with HIPEC surgery for cancer – His results speak for themselves!
– We are greatful to Dr harsh shah had done hipec surgery for my mother.
– we completely satisfied after surgery.
– I will always be grateful to you.
– I will never be able to repay this favor of yours.
– Dr harsh shah is best Gastro cancer surgeon in Ahmedabad, India.
– Thank you so much sir.
My relative was operated for CRS operation. The recovery was smooth. Now being discharged from the hospital. Thank you. Dr Harsh is one of the best Onco surgeon in Ahmedabad.
Explore surgical photographs with caution. Please be advised that viewer discretion is recommended.
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Gastric Cancer: A New Hope
The benefits of HIPEC include:
-Targeted delivery of chemotherapy directly to the abdominal cavity
-Increased effectiveness of chemotherapy due to heat
-Enhanced tumor removal during surgery
-Reduced risk of cancer recurrence
-Potential improvement in survival rates for certain types of advanced abdominal cancers.
The success rate of CRS-HIPEC (Cytoreductive Surgery with HIPEC) varies depending on various factors, including the type and stage of cancer. Success is often measured by the extent of tumor removal and the absence of disease recurrence. Results are better with pseudomyxoma peritonei & ovarian tumours.
Recovery after HIPEC can vary depending on individual factors and the complexity of the surgery. Generally, it may take several weeks to a few months for patients to recover and resume their normal activities.
The survival rate of CRS-HIPEC varies depending on the type and stage of cancer, as well as other individual factors. Survival rates are often discussed in terms of five-year survival, indicating the percentage of patients who survive for at least five years after the procedure. Better survival rates are seen with pseudomyxoma peritonei & ovarian cancers.
HIPEC is used to treat various types of advanced abdominal cancers, including colorectal cancer, gastric cancer, ovary cancer, pancreatic cancer, and pseudomyxoma peritonei.
